The reduced CD4+/CD8+ T lymphocyte ratio reported in clinical studies of patients with cancer suggests that these patients have suppressed cellular immune function and dysfunctional T cells, which make it difficult to clear abnormal cells and contribute to the development of cancer and its progression (Kong et al., 2005; Zhou and Xu, 2012). Here, CD4 is linked to cancer.